Bevacizumab or dexamethasone implants for DME

2-year results (the BEVORDEX study)

Samantha Fraser-Bell, Lyndell L. Lim, Anna Campain, Hemal Mehta*, Christine Aroney, Jaclyn Bryant, Ji Li, Godfrey J. Quin, Ian L. McAllister, Mark C. Gillies

*Corresponding author for this work

    Research output: Contribution to journalComment/opinion

    32 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1399-1401
    Number of pages3
    JournalOphthalmology
    Volume123
    Issue number6
    DOIs
    Publication statusPublished - Jun 2016

    Cite this

    Fraser-Bell, S., Lim, L. L., Campain, A., Mehta, H., Aroney, C., Bryant, J., ... Gillies, M. C. (2016). Bevacizumab or dexamethasone implants for DME: 2-year results (the BEVORDEX study). Ophthalmology, 123(6), 1399-1401. https://doi.org/10.1016/j.ophtha.2015.12.012